Achillion Pharmaceuticals Announces Closing of Public Offering and Exercise of

The offering of 11040000 shares of common stock, including the shares purchased upon exercise of the overallotment option, closed today. The net proceeds to Achillion from the sale of the shares of common stock, after deducting underwriting discounts
See all stories on this topic »